We are live on !
Find out more
Arcadia Wealth Management (New York) Portfolio holdings
AUM
$210M
Turnover
14.75%
1-Year Est. Return
25.07%
This Fund
S&P 500
This Quarter Est. Return
+13.34%
1 Year Est. Return
+25.07%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$210M
AUM Growth
+$24.8M
(+13%)
Cap. Flow
+$2.61M
Cap. Flow % of AUM
Cap. Flow %
1.24%
Top 10 Holdings %
Top 10 Hldgs %
72.81%
Holding
61
New
6
Increased
22
Reduced
12
Closed
3
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis US Equity ETF
AVUS
|
+$1.16M |
| 2 |
Dimensional Short-Duration Fixed Income ETF
DFSD
|
+$401K |
| 3 |
Dimensional International Core Equity Market ETF
DFAI
|
+$381K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$304K |
| 5 |
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
|
+$242K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$683K |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$315K |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$248K |
| 4 |
Palantir
PLTR
|
+$204K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.29% |
| 2 | Technology | 2.34% |
| 3 | Consumer Discretionary | 0.87% |
| 4 | Healthcare | 0.68% |
| 5 | Consumer Staples | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Avantis US Equity ETF
AVUS
$14.6B
| $47.2M | 22.53% |
368,667
+9,398
| +3% | +$1.16M |
2024 Q4
6 quarters
|
|
|
2
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$48.9B
| $42M | 20.06% |
947,460
-5,805
| -0.6% | -$248K |
2024 Q4
6 quarters
|
|
|
3
Dimensional International Core Equity Market ETF
DFAI
$18B
| $16.7M | 7.97% |
404,847
+9,264
| +2% | +$381K |
2024 Q4
6 quarters
|
|
4
Avantis US Small Cap Value ETF
AVUV
$32.1B
| $10.5M | 4.99% |
83,881
+1,253
| +2% | +$149K |
2024 Q4
6 quarters
|
|
|
5
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.34B
| $8.15M | 3.89% |
170,659
+8,376
| +5% | +$401K |
2024 Q4
6 quarters
|
|
6
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$8.85B
| $6.78M | 3.23% |
166,772
+2,335
| +1% | +$91.7K |
2024 Q4
6 quarters
|
|
|
7
iShares Core S&P 500 ETF
IVV
$869B
| $5.73M | 2.73% |
7,646
+417
| +6% | +$304K |
2024 Q4
6 quarters
|
|
8
Dimensional Core Fixed Income ETF
DFCF
$11.7B
| $5.68M | 2.71% |
134,631
+3,238
| +2% | +$137K |
2024 Q4
6 quarters
|
|
|
9
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
$1.71B
| $5.07M | 2.42% |
193,909
+9,424
| +5% | +$242K |
2024 Q4
6 quarters
|
|
10
Avantis International Equity ETF
AVDE
$19.3B
| $4.75M | 2.27% |
53,275
+582
| +1% | +$52.2K |
2024 Q4
6 quarters
|
|
11
Avantis Core Fixed Income ETF
AVIG
$2.01B
| $4.1M | 1.96% |
98,946
+5,016
| +5% | +$208K |
2024 Q4
6 quarters
|
|
|
12
State Street SPDR S&P Biotech ETF
XBI
$10.8B
| $3.99M | 1.91% |
25,235
-2,327
| -8% | -$315K |
2024 Q4
6 quarters
|
|
13
Avantis Emerging Markets Equity ETF
AVEM
$26.4B
| $3.98M | 1.9% |
41,291
-869
| -2% | -$80.1K |
2024 Q4
6 quarters
|
|
14
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $3.56M | 1.7% |
85,227
+3,222
| +4% | +$129K |
2024 Q4
6 quarters
|
|
15
Avantis International Small Cap Value ETF
AVDV
$19.6B
| $3.39M | 1.62% |
32,891
+437
| +1% | +$46.5K |
2024 Q4
6 quarters
|
|
16
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.1B
| $3.15M | 1.5% |
73,020
+1,658
| +2% | +$69.2K |
2024 Q4
6 quarters
|
|
17
Avantis Short-Term Fixed Income ETF
AVSF
$644M
| $3.04M | 1.45% |
65,336
+4,526
| +7% | +$211K |
2024 Q4
6 quarters
|
|
18
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $3M | 1.43% |
8,096
+101
| +1% | +$36.1K |
2024 Q4
6 quarters
|
|
19
Avantis Real Estate ETF
AVRE
$884M
| $2.91M | 1.39% |
61,378
-2,410
| -4% | -$114K |
2024 Q4
6 quarters
|
|
20
Invesco QQQ Trust
QQQ
$466B
| $2.63M | 1.26% |
3,575
-62
| -2% | -$42.7K |
2024 Q4
6 quarters
|
|
21
State Street Technology Select Sector SPDR ETF
XLK
$118B
| $2.49M | 1.19% |
13,061
-80
| -0.6% | -$13.7K |
2024 Q4
6 quarters
|
|
22
iShares Biotechnology ETF
IBB
$11.3B
| $2.46M | 1.17% |
12,914
-875
| -6% | -$150K |
2024 Q4
6 quarters
|
|
23
Apple
AAPL
$5.03T
| $2.14M | 1.02% |
7,391
+88
| +1% | +$25.2K |
2024 Q4
6 quarters
|
|
24
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.54B
| $1.64M | 0.78% |
32,856
-250
| -0.8% | -$12.5K |
2024 Q4
6 quarters
|
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$802B
| $1.56M | 0.75% |
2,092
-60
| -3% | -$43.5K |
2024 Q4
6 quarters
|
|
Similar funds
IF
NED
Arcadia Wealth Management (New York)'s Q2 2026 Portfolio in Review
As of Q2 2026, Arcadia Wealth Management (New York) held 61 positions worth $210M, up 13% from $185M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Arcadia Wealth Management (New York)'s Q2 2026 filing shows 6 new, 22 increased, 12 reduced and 3 closed positions. Its largest new stake was iShares Semiconductor ETF: 465 shares worth $298K. The largest sale was ExxonMobil, an estimated $683K.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Arcadia Wealth Management (New York)'s largest Q2 2026 buy was iShares Semiconductor ETF: 465 shares worth $298K.
- Arcadia Wealth Management (New York) added most to Avantis US Equity ETF in Q2 2026, an estimated $1.16M increase.
- Arcadia Wealth Management (New York)'s biggest Q2 2026 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $315K.
- Arcadia Wealth Management (New York) fully exited ExxonMobil in Q2 2026, selling an estimated $683K.
- Arcadia Wealth Management (New York)'s ten largest holdings make up 73% of its $210M portfolio in Q2 2026.
- Arcadia Wealth Management (New York) opened 6 new positions and closed 3 in Q2 2026.
- Arcadia Wealth Management (New York)'s portfolio value rose 13% quarter-over-quarter to $210M.
Based on Arcadia Wealth Management (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.